Michael Reedijk

Michael Reedijk

UNVERIFIED PROFILE

Are you Michael Reedijk?   Register this Author

Register author
Michael Reedijk

Michael Reedijk

Publications by authors named "Michael Reedijk"

Are you Michael Reedijk?   Register this Author

27Publications

893Reads

40Profile Views

Regulatory T Cells in Ovarian Cancer Are Characterized by a Highly Activated Phenotype Distinct from that in Melanoma.

Clin Cancer Res 2018 11 31;24(22):5685-5696. Epub 2018 Jul 31.

The Campbell Family Institute for Breast Cancer Research, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-18-0554DOI Listing
November 2018

Notch Shapes the Innate Immunophenotype in Breast Cancer.

Cancer Discov 2017 11 8;7(11):1320-1335. Epub 2017 Aug 8.

Campbell Family Institute for Cancer Research, Ontario Cancer Institute, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8290.CD-17-0037DOI Listing
November 2017

B7-H4 expression by nonhematopoietic cells in the tumor microenvironment promotes antitumor immunity.

Cancer Immunol Res 2015 Feb 19;3(2):184-95. Epub 2014 Dec 19.

Campbell Family Institute for Breast Cancer Research, Princess Margaret Cancer Centre, Toronto, Ontario, Canada. Department of Immunology, University of Toronto, Toronto, Ontario, Canada. Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2326-6066.CIR-14-0113DOI Listing
February 2015

High throughput kinase inhibitor screens reveal TRB3 and MAPK-ERK/TGFβ pathways as fundamental Notch regulators in breast cancer.

Proc Natl Acad Sci U S A 2013 Jan 14;110(5):1714-9. Epub 2013 Jan 14.

Campbell Family Institute for Breast Cancer Research, Ontario Cancer Institute, Toronto, ON, Canada M5G 2M9.

View Article

Download full-text PDF

Source
http://www.pnas.org/cgi/doi/10.1073/pnas.1214014110
Publisher Site
http://dx.doi.org/10.1073/pnas.1214014110DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3562766PMC
January 2013

Metformin in early breast cancer: a prospective window of opportunity neoadjuvant study.

Breast Cancer Res Treat 2012 Oct 30;135(3):821-30. Epub 2012 Aug 30.

Division of Medical Oncology and Hematology, Department of Medicine, Mount Sinai Hospital and Princess Margaret Hospital, University of Toronto, 1284-600 University Avenue, Toronto, ON M5G 1X5, Canada.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10549-012-2223-1
Publisher Site
http://dx.doi.org/10.1007/s10549-012-2223-1DOI Listing
October 2012

A prospective study of tumor and technical factors associated with positive margins in breast-conservation therapy for nonpalpable malignancy.

Am J Surg 2012 Sep 12;204(3):263-8. Epub 2012 Jul 12.

Department of Surgical Oncology, Princess Margaret Hospital, University Health Network, 610 University Ave., Suite 3-130, Toronto, Ontario, Canada M5G 2M9.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjsurg.2012.03.007DOI Listing
September 2012

Developmental pathways in breast cancer and breast tumor-initiating cells: therapeutic implications.

Cancer Lett 2012 Apr 26;317(2):115-26. Epub 2011 Nov 26.

Campbell Family Institute for Breast Cancer Research, Ontario Cancer Institute, 620 University Avenue, Toronto, Ontario, Canada M5G 2M9.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canlet.2011.11.028DOI Listing
April 2012

Notch signaling and breast cancer.

Authors:
Michael Reedijk

Adv Exp Med Biol 2012 ;727:241-57

Department of Surgical Oncology, University Health Network, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-1-4614-0899-4_18DOI Listing
April 2012

A multicentered, randomized, controlled trial comparing radioguided seed localization to standard wire localization for nonpalpable, invasive and in situ breast carcinomas.

Ann Surg Oncol 2011 Nov 30;18(12):3407-14. Epub 2011 Apr 30.

Department of Surgery, McMaster University, and St. Joseph's Healthcare, Hamilton, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-011-1699-yDOI Listing
November 2011

Notch signaling pathway as a therapeutic target in breast cancer.

Mol Cancer Ther 2011 Jan 22;10(1):9-15. Epub 2010 Oct 22.

University of Toronto, Princess Margaret Hospital, 610 University Avenue, Suite 5-222, Toronto, Ontario, M5G 2M9.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-10-0677DOI Listing
January 2011

Plasminogen activator uPA is a direct transcriptional target of the JAG1-Notch receptor signaling pathway in breast cancer.

Cancer Res 2011 Jan;71(1):277-86

Campbell Family Institute for Breast Cancer Research, Ontario Cancer Institute, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-10-2523DOI Listing
January 2011

Cyclin D1 is a direct target of JAG1-mediated Notch signaling in breast cancer.

Breast Cancer Res Treat 2010 Aug 14;123(1):113-24. Epub 2009 Nov 14.

Campbell Family Institute for Breast Cancer Research, Ontario Cancer Institute, Toronto, Canada.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10549-009-0621-9
Publisher Site
http://dx.doi.org/10.1007/s10549-009-0621-9DOI Listing
August 2010

Expression profiling of familial breast cancers demonstrates higher expression of FGFR2 in BRCA2-associated tumors.

Breast Cancer Res Treat 2009 Sep 18;117(1):183-91. Epub 2008 Jun 18.

Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-008-0087-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2727582PMC
September 2009

Activation of Notch signaling in human colon adenocarcinoma.

Int J Oncol 2008 Dec;33(6):1223-9

Program in Developmental Biology and Stem Cell Research, The Hospital for Sick Children, MaRS East Tower, Ontario M5G 1L7, Canada.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2739737PMC
http://dx.doi.org/10.3892/ijo_00000112DOI Listing
December 2008

JAG1 expression is associated with a basal phenotype and recurrence in lymph node-negative breast cancer.

Breast Cancer Res Treat 2008 Oct 8;111(3):439-48. Epub 2007 Nov 8.

Department of Surgical Oncology, University of Toronto, Toronto, ON, Canada, M5G 2M9.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-007-9805-3DOI Listing
October 2008

Sentinel nodes in breast cancer: relevance of axillary level II nodes and optimal number of nodes that need to be removed.

Ann Surg Oncol 2008 Jun 7;15(6):1710-6. Epub 2008 Mar 7.

Department of Surgical Oncology, Princess Margaret Hospital, University Health Network and University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-008-9858-5DOI Listing
June 2008

High-level JAG1 mRNA and protein predict poor outcome in breast cancer.

Mod Pathol 2007 Jun;20(6):685-93

Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/modpathol.3800785DOI Listing
June 2007

A case of axillary web syndrome with subcutaneous nodules following axillary surgery.

Breast 2006 Jun 28;15(3):411-3. Epub 2005 Oct 28.

Department of Surgical Oncology, Princess Margaret Hospital, University Health Network and the University of Toronto, 610 University Avenue, Toronto, Ontario, Canada M5G 2M9.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.breast.2005.09.005DOI Listing
June 2006